Trials / Completed
CompletedNCT00180297
Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
Evaluation of the Success Rate and the Clinical Evolution of a Ventricular Lead Implanted in the Septum Versus the Right Ventricular Apex.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 215 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of the implant of a ICD lead of defibrillation in the septum of the right ventricle
Detailed description
The rate of success at implant and the positive clinical outcomes for the patients implanted with a lead of defibrillation at the septal site would make it possible to recommend this site as a "new standard" for implant of the defibrillation lead in the RV for ICD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endotak Reliance G | Reliance G is a defibrillation lead to be placed in the right ventricle. |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2005-09-16
- Last updated
- 2021-10-14
- Results posted
- 2021-07-01
Locations
18 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00180297. Inclusion in this directory is not an endorsement.